bdtx: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	50	-84
Net (decrease) increase in cash and cash equivalents	-5,565	-6,439
Cash and cash equivalents at beginning of period	37,256	-
Cash and cash equivalents at end of period	31,691	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	50	-84
Net (decrease) increase in cash and cash equivalents	-5,565	-6,439
Cash and cash equivalents at beginning of period	37,256	-
Cash and cash equivalents at end of period	31,691	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Black Diamond Therapeutics, Inc. (BDTX)